R&D

News

UK backs startup Potential Sciences' AI-powered drug hunt

UK startup Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.

News

AbbVie invests £120m in UK expansion

AbbVie has pledged another £120 million to the UK, reinforcing the country's recovery as a pharma industry investment hotspot.

News

German sites added to Europe's cardiometabolic R&D network

The BioInnovation Institute (BII) has expanded a European network to develop drugs for cardiometabolic diseases and launch new biotechs into Germany.

R&D

Clinical Trials Round-Up: July/August 2026

While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.

News

Chemistry Nobel goes to molecular chirality researchers

The Nobel Prize in Chemistry 2026 has been awarded to Henri B Kagan and Kensō Soai for their discoveries in asymmetric organic synthesis.

News

AstraZeneca cuts ribbon on new R&D facility in Massachusetts

AstraZeneca's has opened a new R&D centre in the biotech hotspot of Cambridge, Massachusetts, the centrepiece of a $1bn investment in the state.

R&D

Editor's Picks